Calreticulin, an Antithrombotic Agent Which Binds to Vitamin K-dependent Coagulation Factors, Stimulates Endothelial Nitric Oxide Production, and Limits Thrombosis in Canine Coronary Arteries
Authors:
Open Access
- 1 April 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (14) , 8179-8187
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The endothelial cell binding determinant of human factor IX resides in the .gamma.-carboxyglutamic acid domainBiochemistry, 1992
- Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.Journal of Clinical Investigation, 1991
- Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.Journal of Clinical Investigation, 1991
- Sequence homology of a canine brain calcium-binding protein with calregulin and the human RoSS-A antigenBiochemical and Biophysical Research Communications, 1989
- Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.Journal of Clinical Investigation, 1989
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- In vivo evidence of intravascular binding sites for coagulation factor IXBritish Journal of Haematology, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.Journal of Experimental Medicine, 1986
- Protein iodination with solid state lactoperoxidaseBiochemistry, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970